Bryan Lawrence · Q4 2021
Oakcliff Capital
Portfolio at the end of Q4 2021, from the 13F filed February 14, 2022. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Charter Communications CHTR · history | 19.0% | Q4 2017 | Reduce 14% |
| TransDigm TDG · history | 16.2% | Q1 2017 or earlier | No change |
| Alphabet GOOG · history | 12.1% | Q1 2018 | No change |
| Carvana CVNA · history | 9.7% | Q3 2018 | No change |
| Interactive Brokers IBKR · history | 9.5% | Q1 2017 or earlier | No change |
| Cardlytics CDLX · history | 9.2% | Q3 2019 | Add 12% |
| Guidewire GWRE · history | 7.5% | Q4 2020 | No change |
| Star Group SGU · history | 6.4% | Q1 2017 or earlier | No change |
| Alteryx AYX · history | 5.4% | Q3 2020 | No change |
| GoodRx GDRX · history | 4.4% | Q4 2021 | Buy |
| Hallador Energy HNRG · history | 0.6% | Q1 2017 or earlier | No change |
| 11 positions | 100% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2021, adjusted for stock splits.
Sector weighting
| Technology | 34.2% | |
|---|---|---|
| Media & telecom | 19.0% | |
| Industrials | 16.2% | |
| Consumer discretionary | 9.7% | |
| Financials & real estate | 9.5% | |
| Energy | 7.0% | |
| Health care | 4.4% |
What changed from Q3 2021
- Buy GoodRx GDRX 4.4% of the 13F
- Add 12% Cardlytics CDLX 10.1% → 9.2%
- Reduce 14% Charter Communications CHTR 23.8% → 19.0%